“How long does medical device registration in Malaysia take?”
The answer depends on several factors, including the device risk class, product grouping, technical documentation readiness, whether conformity assessment is required, whether the device has recognized foreign approvals, and how quickly the manufacturer can respond to queries from the conformity assessment body or the Medical Device Authority, also known as MDA.
For overseas manufacturers, the registration timeline is not only a regulatory question. It affects distributor appointment, launch planning, tender participation, revenue forecasting, shipment planning, and market-entry strategy.
This article explains the typical timeline considerations for Malaysia medical device registration, why timelines vary by product class, what causes delays, and how foreign manufacturers can prepare for a smoother registration process.
Malaysia regulates medical devices under the Medical Device Act 2012, also known as Act 737.
MDA states that, under Section 5(1) of the Medical Device Act 2012, no medical device shall be imported, exported, or placed in the Malaysian market unless the medical device is registered under the Act.
This means that before a foreign manufacturer can commercially supply a medical device in Malaysia, the product generally needs to go through the applicable registration process.
The registration process is submitted through MeDC@St, MDA’s web-based online application system for establishment licensing and medical device registration. MDA describes MeDC@St as a centralized online system that enables applicants to submit applications for establishment licensing and medical device registration.
For medical devices manufactured outside Malaysia, the registration is usually managed through a local authorized representative, commonly abbreviated as AR.
In commercial language, this party may also be called:
- Medical device license holder;
- Independent license holder;
- Local representative;
- Registration holder;
- Malaysia medical device AR;
- Local regulatory representative.
In practice, there is no single fixed timeline that applies to every medical device registration in Malaysia.
The approval timeline depends on:
- Medical device class;
- Device type;
- Whether the device is general medical device or IVD;
- Whether conformity assessment is required;
- Whether the product has recognized foreign approvals;
- Whether the dossier is complete;
- Whether the product grouping is straightforward;
- Whether the labelling and IFU meet Malaysian requirements;
- Whether the CAB or MDA raises queries;
- How quickly the manufacturer responds to queries.
Although each project must be assessed individually, the general principle is simple:
Lower-risk devices are usually faster, while higher-risk devices usually take longer.
| Medical Device Class | Risk Level | General Timeline Complexity |
| Class A | Low risk | Usually the simplest and fastest |
| Class B | Low to moderate risk | Moderate timeline, depending on conformity assessment and documentation |
| Class C | Moderate to high risk | Longer timeline due to more detailed review |
| Class D | High risk | Usually the longest and most complex |
Class A medical devices are low-risk devices.
Examples may include certain non-sterile, non-measuring devices such as simple hospital accessories, basic surgical instruments, or other low-risk products, depending on their intended use and classification.
Class A registration is generally more straightforward than Class B, C, or D registration because the risk level is lower and the documentation burden is usually lighter.
However, foreign manufacturers should still prepare:
- Product information;
- Device description;
- Intended use;
- Product classification rationale;
- Labelling and IFU, where applicable;
- Manufacturer information;
- AR’s information;
- Supporting documentation required by the MeDC@St system.
Practical Planning Estimate
For Class A devices, manufacturers may often plan for a shorter timeline compared with higher-risk devices, but the actual timing depends on document readiness, application completeness, and MDA processing.
Class B devices are low to moderate risk.
Examples may include certain wound dressings, non-invasive devices, basic monitoring devices, or other devices depending on their intended use and classification.
Compared with Class A, Class B devices usually require more technical documentation and may require conformity assessment before MDA submission.
The timeline may depend on:
- Whether the device has prior foreign approval;
- Whether conformity assessment can proceed through a verification route;
- Whether the technical file is complete;
- Whether clinical or performance evidence is sufficient;
- Whether there are labelling issues;
- Whether the CAB raises questions.
For Class B devices, foreign manufacturers should generally expect a longer timeline than Class A, particularly if the dossier is incomplete or conformity assessment is required.
A practical planning range may be several months, depending on conformity assessment route, document readiness, and review queries.
Class C devices are moderate to high-risk devices.
Examples may include more complex active devices, certain higher-risk wound care products, certain monitoring or treatment devices, and other devices depending on classification rules.
Class C registration usually requires a more detailed review. The technical file must be stronger and should normally include a complete set of safety, performance, risk management, clinical, labelling, and quality management documentation.
Class C registration may take longer because of:
- Higher technical scrutiny;
- More detailed conformity assessment;
- Greater likelihood of CAB queries;
- Need for complete clinical evaluation;
- More complex product grouping;
- More detailed labelling review;
- Possible need to justify equivalence, safety, and performance claims.
For Class C devices, manufacturers should plan for a longer timeline, commonly several months and sometimes longer if the product does not have recognized foreign approvals or if the dossier requires significant gap closure.
For higher-risk devices without strong reference approvals, manufacturers should be conservative in launch planning.
Class D devices are high-risk medical devices.
Examples may include high-risk implantable devices, life-supporting or life-sustaining devices, certain high-risk IVDs, or other products depending on classification.
Class D registration is typically the most complex because the potential risk to patients and users is higher.
Timeline challenges may include:
- Extensive technical documentation;
- More detailed clinical evidence;
- Higher CAB review complexity;
- More MDA scrutiny;
- More queries;
- More complex risk management;
- More detailed post-market history review;
- Possible need for additional supporting evidence.
For Class D devices, manufacturers should generally plan for the longest registration timeline. If the dossier is incomplete or there are no recognized foreign approvals, the process may be significantly longer.
A conservative planning approach is recommended, especially if the manufacturer has distributor launch commitments, tender deadlines, or hospital procurement targets.
The Malaysia medical device registration process can be divided into several stages.
Stage 1: Product Classification Review
Before submission, the product must be classified correctly.
This includes reviewing:
- Intended use;
- Indications for use;
- Duration of contact;
- Invasiveness;
- Whether the device is active or non-active;
- Whether the product is implantable;
- Whether the device is sterile or measuring;
- Whether the product is an IVD;
- Whether it has software functions;
- Whether it includes medicinal substances.
For foreign manufacturers, the local AR or medical device license holder must be appointed.
This stage includes:
- Confirming the AR’s role;
- Signing appointment documents;
- Confirming establishment license status;
- Defining regulatory responsibilities;
- Confirming whether the AR is independent or distributor-linked.
If the distributor holds the registration, the timeline may be affected later if the manufacturer wants to change distributors or appoint additional distributors.
This is often one of the biggest factors affecting timeline.
Manufacturers should prepare documents such as:
- Product brochure;
- Instructions for use;
- Product labels;
- Device description;
- Intended use statement;
- Product specifications;
- Model list and accessories list;
- Risk analysis;
- Risk management report;
- Essential principles checklist;
- Clinical evaluation or performance evaluation;
- Declaration of conformity;
- ISO 13485 certificate;
- Certificate of market authorization, where applicable;
- Existing approvals from reference markets, where applicable;
- Test reports;
- Biocompatibility data, where applicable;
- Sterilization validation, where applicable;
- Shelf-life and packaging validation, where applicable;
- Electrical safety and EMC reports, where applicable;
- Software validation, cybersecurity, or usability data, where applicable;
- Adverse event, recall, and field safety corrective action declaration.
Product grouping affects how many applications are required.
A manufacturer may have multiple:
- Sizes;
- Models;
- Configurations;
- Accessories;
- Brands;
- Intended uses;
- Manufacturing sites;
- Technologies.
If grouping is not reviewed early, the manufacturer may underestimate cost and timeline.
For many Class B, C, and D devices, conformity assessment by a registered conformity assessment body may be required before MDA registration.
MDA’s regulatory framework includes registration of conformity assessment bodies for quality systems certification and product testing, and conformity assessment is listed as part of the medical device registration information resources.
CAB review can be one of the longest parts of the process.
Timeline depends on:
- CAB workload;
- Device class;
- Application route;
- Completeness of the dossier;
- Quality of the clinical evidence;
- Whether the product has recognized foreign approval;
- Number of queries;
- Manufacturer response time.
Once the necessary documentation and conformity assessment output are ready, the AR submits the registration application through MeDC@St.
MDA describes MeDC@St as the platform used by industry players to submit applications for registration of medical devices and licensing of establishments under the Act.
The submission stage may be delayed if:
- The MeDC@St account is not ready;
- Required fields are incomplete;
- Documents are not in the required format;
- Product details do not match supporting documents;
- Application fees are not paid;
- Product grouping is unclear.
After submission, MDA reviews the application.
Queries may relate to:
- Classification;
- Grouping;
- Product name;
- Intended use;
- Manufacturer details;
- AR information;
- Labelling;
- IFU;
- CAB documents;
- Technical file consistency;
- Post-market history;
- Prior approvals.
Once the review is completed and all requirements are satisfied, registration approval is granted.
The manufacturer and AR should check:
- Registration ID;
- Approved product name;
- Approved models;
- Approved accessories;
- Risk class;
- Manufacturer information;
- AR information;
- Approved scope;
- Registration validity and maintenance requirements.
Several issues commonly delay Malaysia registration.
1. Incomplete Technical Documentation
This is one of the most common causes of delay.
For example, manufacturers may lack:
- Complete risk management file;
- Clinical evaluation;
- Valid ISO 13485 certificate;
- Declaration of conformity;
- Labelling and IFU;
- Test reports;
- Sterilization validation;
- Shelf-life data;
- Biocompatibility data;
- Post-market history.
If the device classification is not clear, the application route, fees, and documentation expectations may also be unclear.
Borderline products can take longer, especially when they sit between medical device and non-medical device categories.
Examples include:
- Wellness products;
- Cosmetic-medical borderline products;
- Disinfection products;
- Software applications;
- Health monitoring devices;
- Combination products.
If the manufacturer submits the wrong grouping structure, the application may require correction or separation.
This affects:
- Cost;
- Timeline;
- Submission strategy;
- Distributor launch planning;
- Product listing coverage.
Devices with recognized foreign approval may be eligible for a more efficient conformity assessment route, depending on the applicable MDA requirements and product circumstances.
However, if the product has no recognized foreign approval, the review may be more detailed and may take longer.
MDA’s registration information page includes resources on recognized foreign regulatory authorities and notified bodies, and approval types eligible for conformity assessment by way of verification process.
CAB queries can add time, especially for higher-risk products.
Common CAB queries include:
- Missing clinical evidence;
- Insufficient risk analysis;
- Incomplete labelling;
- Inconsistent product model information;
- Missing test reports;
- Expired certificates;
- Unclear manufacturing site information;
- Incomplete post-market data.
Even if the AR works quickly, the timeline may be delayed if the manufacturer takes too long to respond to questions.
Foreign manufacturers should assign a regulatory contact person who can quickly gather documents and provide technical clarifications.
Malaysia labelling requirements must be checked carefully.
The label and IFU should be consistent with:
- Intended use;
- Product name;
- Manufacturer details;
- AR details, where applicable;
- Warnings and precautions;
- Instructions for use;
- Symbols and claims;
- Approved product scope.
Delays may occur if:
- ISO 13485 certificate is expired;
- CE certificate is expired;
- Product name differs across documents;
- Manufacturer name differs across documents;
- Manufacturing site differs across certificates;
- Model list differs across approvals and IFU.
Manufacturers cannot fully control the authority review timeline, but they can reduce avoidable delays.
1. Prepare a Complete Technical File Early
Before starting Malaysia registration, prepare a complete technical file.
A strong dossier reduces back-and-forth queries.
2. Confirm Classification Before Quotation
Classification affects cost, timeline, and required documents.
Do not quote distributors or customers until the classification is reasonably confirmed.
3. Conduct Product Grouping Assessment Early
Grouping affects how many applications are needed.
This should be done before confirming the project scope.
4. Appoint an Experienced AR
A reliable AR or license holder can help identify issues early, coordinate documents, and manage the submission properly.
5. Separate Regulatory Control from Distributor Sales
Using an independent license holder may prevent commercial delays later if the distributor relationship changes.
6. Use Existing Foreign Approvals Where Applicable
If the product has approvals from recognized markets, prepare those certificates and supporting documents early.
7. Respond Quickly to Queries
Set up an internal response process with the manufacturer’s regulatory, quality, clinical, and technical teams.
8. Check Certificate Validity
Confirm that ISO 13485, free sale certificates, CE certificates, FDA clearances, and other approvals are valid and consistent.
9. Review Labelling Before Submission
Labelling and IFU should be reviewed before application submission to prevent avoidable queries.
10. Avoid Last-Minute Distributor Pressure
Do not promise a launch date before the registration pathway, documentation readiness, and conformity assessment requirements are understood.
A practical timeline plan should include four layers:
1. Pre-Submission Preparation Timeline
This includes classification, grouping, document collection, dossier review, and AR appointment.
This stage may be short if documents are ready, or long if the manufacturer needs to prepare missing technical data.
2. CAB Conformity Assessment Timeline
This applies mainly to devices that require CAB review.
The duration depends on device class, review route, and query cycles.
3. MDA Submission and Review Timeline
This includes MeDC@St submission, MDA review, query response, and approval.
4. Post-Approval Commercial Readiness Timeline
After registration approval, the manufacturer still needs to coordinate:
- Importer appointment;
- Distributor authorization;
- Labelling implementation;
- Shipment planning;
- Tender preparation;
- Post-market procedure alignment.
| Stage | Key Activities | Main Delay Risk |
| Product classification | Confirm device class and route | Borderline classification |
| AR appointment | Appoint Malaysia AR | Contract or authorization delay |
| Document collection | Gather technical file | Missing documents |
| Grouping assessment | Confirm application structure | Incorrect grouping |
| CAB review | Conformity assessment, if required | CAB queries |
| MeDC@St submission | Online application submission | Incomplete fields or documents |
| MDA review | Authority review and queries | Technical or labelling queries |
| Approval | Registration issued | Pending clarification |
| Post-approval setup | Importer/distributor coordination | Commercial readiness delay |
Scenario 1: Class A Device With Complete Documents
This is usually the fastest scenario.
The manufacturer has complete product information, clear intended use, correct classification, and no complex grouping issues.
Scenario 2: Class B Device With Recognized Foreign Approval
This may proceed more smoothly if the approval documents, technical file, labelling, and ISO 13485 certificate are complete.
However, CAB review and MDA submission must still be managed properly.
Scenario 3: Class C Device Without Complete Clinical Evidence
This may take longer because the manufacturer may need to close clinical or performance evidence gaps before or during CAB review.
Scenario 4: Class D Device Without Recognized Foreign Approval
This is usually a longer and higher-complexity pathway.
The manufacturer should plan conservatively and avoid promising early launch dates.
Scenario 5: Combination Product
Drug-medical device or medical device-drug combination products may involve more complex timelines. MDA’s combination product guideline includes separate working-day timelines for evaluation stages, showing that these products require careful planning beyond a standard device-only pathway.
The registration timeline directly affects distributor planning.
Foreign manufacturers should avoid appointing distributors based only on enthusiasm or early commercial interest.
Before finalizing distributor commitments, consider:
- Whether the distributor should hold the registration;
- Whether an independent license holder is better;
- Whether multiple distributors may be appointed later;
- Whether tender deadlines are realistic;
- Whether the distributor understands that registration takes time;
- Whether the distributor can support post-approval importation and supply;
- Whether pricing and territory commitments should wait until the timeline is clearer.
There are two possible approaches.
Option 1: Find Distributor First
This may work if the distributor is experienced, trusted, and has strong market access.
However, if the distributor holds the registration, the manufacturer may face distributor lock-in later.
Option 2: Appoint Independent License Holder First
This allows the manufacturer to start registration while still evaluating distributors.
It is often better when the manufacturer wants:
- Long-term control;
- Multiple distributor flexibility;
- Independent regulatory structure;
- Avoidance of distributor lock-in;
- Easier distributor replacement.
Mistake 1: Assuming Class A, B, C and D Have the Same Timeline
Higher-risk devices usually require more technical review and may take longer.
Mistake 2: Starting Registration Without Complete Documents
Incomplete documents are one of the biggest causes of delay.
Mistake 3: Ignoring CAB Review Time
For many Class B, C, and D devices, CAB review can be a major part of the timeline.
Mistake 4: Promising Distributors a Launch Date Too Early
Launch dates should only be planned after classification, grouping, document readiness, and conformity assessment route are understood.
Mistake 5: Letting the Distributor Control Registration Without Considering Long-Term Strategy
This may delay future distributor changes or market expansion.
Mistake 6: Not Checking Existing Approval Validity
Expired or inconsistent approvals may slow down the review process.
Mistake 7: Forgetting Post-Approval Readiness
Even after approval, importation, distribution, labelling, and post-market arrangements must be prepared.
1. How long does medical device registration take in Malaysia?
There is no single fixed timeline for all medical devices. The timeline depends on device class, documentation readiness, conformity assessment requirements, existing foreign approvals, CAB review, MDA review, and query response time.
2. Is Class A medical device registration faster in Malaysia?
Class A devices are generally lower risk and usually simpler than Class B, C, and D devices. However, the actual timeline still depends on application completeness and MDA processing.
3. Why do Class C and Class D devices take longer?
Class C and D devices are higher-risk devices and generally require more detailed technical documentation, stronger clinical or performance evidence, more detailed conformity assessment, and more careful regulatory review.
4. Does having CE, FDA, TGA, Health Canada, or Japan approval shorten the Malaysia timeline?
Existing approval from recognized markets may support a more efficient conformity assessment route, depending on the applicable MDA requirements and product circumstances. MDA’s registration information includes resources on recognized foreign regulatory authorities and approval types eligible for conformity assessment by verification process.
5. What is MeDC@St?
MeDC@St is MDA’s web-based online application system for establishment licensing and medical device registration.
6. Does the authorized representative (AR) affect the timeline?
Yes. An experienced AR can help identify documentation gaps, coordinate the registration pathway, manage MeDC@St submission, respond to queries, and reduce avoidable delays.
7. Can a foreign manufacturer start Malaysia registration without a distributor?
Yes. A foreign manufacturer can appoint an independent AR or medical device license holder first, then appoint distributors separately. This can help avoid distributor lock-in.
8. What causes the most delays?
Common causes include incomplete technical documentation, unclear classification, poor grouping strategy, missing clinical evidence, CAB queries, labelling issues, expired certificates, and slow manufacturer responses.
9. Should the distributor hold the registration to speed up the timeline?
Not necessarily. A distributor may be familiar with the market, but allowing a distributor to hold the registration can create long-term commercial risks. An independent license holder may provide better regulatory control and distributor flexibility.
10. Can the timeline be guaranteed?
No. The timeline cannot be guaranteed because it depends on authority review, CAB review, document completeness, query cycles, and product complexity. A realistic estimate should be provided only after initial classification and document review.
Malaysia medical device registration timelines vary depending on the product class, registration route, conformity assessment requirements, reference country approvals, technical documentation readiness, and review queries from the conformity assessment body or MDA.
As a general practical planning estimate, foreign manufacturers may consider the following indicative timelines:
| Medical Device Category / Route | Practical Planning Estimate |
| Class A medical device | Approximately 2 to 3 months |
| Class B, C and D medical devices with reference agency approval | Approximately 4 to 6 months |
| Class B, C and D medical devices without reference agency approval | Approximately 6 to 9 months |
Class A devices are usually simpler, while Class B, C and D devices generally require more detailed documentation and may involve conformity assessment. For products with reference agency approvals, the review pathway may be more efficient if the supporting approval documents are complete and eligible. For products without reference agency approvals, the review may take longer because a more detailed assessment may be required.
For foreign manufacturers, the best way to manage the Malaysia registration timeline is to prepare the technical documentation early, confirm product classification and grouping before submission, appoint a reliable Malaysia AR, and respond quickly to CAB or MDA queries.
The registration timeline should also be considered together with the manufacturer’s distributor strategy. Using an independent medical device license holder can help foreign manufacturers start registration while preserving long-term flexibility to appoint, change, or expand distributors in Malaysia.
We support foreign medical device manufacturers with Malaysia MDA medical device registration, authorized representative services, independent license holding, conformity assessment coordination, document gap review, distributor coordination, and post-market compliance planning.
Whether you are preparing a Class A, B, C, or D medical device submission, our team can help you assess the expected registration pathway, timeline risks, and market-entry strategy.
Contact us today to discuss your Malaysia medical device registration timeline and license holding requirements.
